FDA warns of liver damage reports with Sanofi drug
January 14, 2011 By MATTHEW PERRONE , AP Health Writer
(AP) -- Federal health officials are warning doctors and patients that a recently-launched heart drug from Sanofi-Aventis SA has been linked to liver damage in a handful of patients.
The Food and Drug Administration said Friday it has received several reports of liver damage with Multaq tablets, including two cases in which patients had to have their livers removed. Both patients were women and roughly 70 years old. They had been taking the drug for 4.5 months and 6 months, respectively.
The FDA approved Multaq in July 2009 to treat atrial flutter and atrial fibrillation which are irregular heart rhythms that can reduce blood flow and lead to stroke. More than a half-million prescriptions for Multaq have been written since the drug was approved.
In an online notice, the FDA said it would add a new warning about the risk for liver damage to the label of Multaq. The agency said patients should contact their doctor if they experience signs of liver injury, including nausea, vomiting and fever. If doctors suspect a toxicity issue they should discontinue use of the drug and test the patient's liver enzymes.
Liver toxicity is among the most common drug-related side effects across a number of medication classes.
Multaq already carries a black box warning, the most severe type, stating the drug can cause severe complications, including death, in people with recent severe heart failure and should not be used in those patients. Common side effects of the twice-a-day tablets include fatigue, loss of strength, diarrhea, nausea and vomiting.
Paris-based Sanofi reported $84 million in sales for Multaq in the first-half of 2009.
Leerink Swann analyst Seamus Fernandez said the safety warning is unlikely to hurt U.S. sales of drug, which he estimates at $128 million for 2010 and $521 million by 2016.
Sanofi said in a statement it has already issued a letter about the liver injuries to doctors and other health care professionals who prescribe Multaq. The letter recommends prescribers consider giving liver enzyme tests during the first six months of treatment.
"Sanofi-Aventis will continue to be in communication with the FDA and this issue will be closely reviewed and monitored," the company stated.
©2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
From lemons to lemonade: Reaction uses carbon dioxide to make carbon-based semiconductor,
28 comments
-
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments,
3 comments
-
SpaceX private rocket blasts off for space station (Update),
41 comments
-
Climate scientists say they have solved riddle of rising sea,
30 comments
-
Scotland passes turbine test to harness tidal power,
40 comments
-
Potential Breakthrough in Seizure Control
8 hours ago
-
Popping/Cracked sternum.
13 hours ago
-
Which Mental Illness Encompasses This Problem?
13 hours ago
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
- More from Physics Forums - Medical Sciences
More news stories
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Medicine & Health / Alzheimer's disease & dementia
3 hours ago |
not rated yet |
0
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
3 hours ago |
not rated yet |
0
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Medicine & Health / Inflammatory disorders
4 hours ago |
not rated yet |
1
|
Skp2 activates cancer-promoting, glucose-processing Akt
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
21 hours ago |
not rated yet |
0
|
Tongue analysis software uses ancient Chinese medicine to warn of disease
For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...
19 hours ago |
1 / 5 (1) |
0
|
SpotterRF debuts Radar Backpack Kit (w/ Video)
(Phys.org) -- SpotterRF has announced a special radar backpack kit designed to enhance situational awareness for soldiers on the ground. The company says its special radar is designed for warfighters as part ...
Australia hails surprise super-telescope decision
Australia has hailed a surprise decision giving it a role in a radio telescope project aimed at revolutionising astronomy, vowing to draw on its decades of experience in space science.
Astronomers seize last chance in lifetime for Venus Transit
Astronomers are gearing for one the rarest events in the Solar System: an alignment of Earth, Venus and the Sun that will not be seen for another 105 years.
SpaceX capsule has 'new car' smell, astronauts say
SpaceX's Dragon cargo vessel smells like a new car, said astronauts at the International Space Station after opening the hatches Saturday following the spacecraft's landmark mission to the orbiting lab.
Thousands of shellfish found dead in Peru
Thousands of crustaceans were found dead off the coast of Lima following the mystery mass death of dolphins and pelicans, the Peruvian Navy said Friday.
Astronauts enter world's 1st private supply ship
(AP) -- Space station astronauts floated into the Dragon on Saturday, a day after its heralded arrival as the world's first commercial supply ship.